9th RNA-Targeted Drug Discovery & Development Summit

The 9th RNA-Targeted Drug Discovery & Development Summit is the industry's only dedicated conference focused exclusively on advancing RNA-targeted small molecules from discovery through translation and clinical development. Bringing together leading scientists and decision-makers from pioneering biotechs, global pharmaceutical companies, and academia, the meeting serves as the central forum for sharing breakthroughs, overcoming technical challenges, and accelerating the development of next-generation RNA-targeted therapeutics.

Attendees will gain insights into the latest advances in RNA target selection, structure-guided design, direct RNA binding, splice modulation, RNA degradation, covalent translation inhibition, epitranscriptomic regulation, and emerging RNA-targeting technologies. Through expert-led presentations, interactive workshops, case studies, and networking discussions, participants will explore practical strategies to improve selectivity, optimize drug discovery workflows, and translate RNA-targeted small molecules into impactful therapies for oncology, rare genetic, and neurodegenerative diseases.

Featuring speakers and attendees from organizations including PTC Therapeutics, ReviR Therapeutics, Remix Therapeutics, AstraZeneca, Sanofi, Dewpoint Therapeutics, Arrakis Therapeutics, and more, this summit offers a unique opportunity to connect with the global RNA-targeted drug discovery community and shape the future of the field.

Download the event guide to learn more, or register your place with our exclusive 10% discount code: BPT10